Clinical Genetics · 2014 · 17 citations · 16 references
Life SciencesGeneticsOncologyCancer GeneticsHuman GeneticsMedical GeneticsCancer RiskGenetic Risk AssessmentGermline Cancer PredispositionGermline Cancer SusceptibilityHereditary Cancer SyndromesHereditary Gastrointestinal Cancer SyndromesFamilial Gastric CancerGastric Cancer GeneticsGastric Cancer PrevalenceHereditary Cancer RiskHereditary Cancer ScreeningInherited Cancer RiskInternational Cancer ComparisonsLi-fraumeni Syndrome
Type of cancer and age of onset in individuals with inherited aberrations in the tumour suppressor gene TP53 are variable, possibly influenced by genetic modifiers and different environmental exposure. Since 2009, the modified Chompret criteria (MCC) have been used to identify individuals for TP53 mutation screening. Using the TP53 mutation database maintained by the International Agency for Research on Cancer (IARC), we investigated if the MCC, mainly developed for a Caucasian population, was also applicable in Asia. We identified several differences in Asian families compared with similar Caucasian cohorts, suggesting that identification and management of Li-Fraumeni syndrome in Asia do not completely mirror that of North America and Western Europe. Early gastric cancer (<40 years) may be considered a new addition to the MCC especially for Asian families.
16
Crystal Structure of a p53 Tumor Suppressor-DNA Complex: Understanding Tumorigenic Mutations
Yunje Cho, Svetlana S. Gorina, Philip D. Jeffrey et al. · Science · 1994 · 2.5K citations
The IARC TP53 database: New online mutation analysis and recommendations to users
Magali Olivier, Rosalind A. Eeles, Monica Hollstein et al. · Human Mutation · 2002 · 1.3K citations
Heterozygous Germ Line <i>hCHK2</i> Mutations in Li-Fraumeni Syndrome
Daphne W. Bell, Jennifer M. Varley, Tara E. Szydlo et al. · Science · 1999 · 902 citations
David Malkin · Genes & Cancer · 2011 · 508 citations · Full text
Life Sciences, Genetics, Oncology +17